Inhibition of furin-mediated cleavage activation of HIV-1 glycoprotein gpl60

Cited by (586)

Items 401–500 of 586

1. Replication of HIV-1 viruses in the presence of the Portland α1-antitrypsin variant (α1-PDX) inhibitor
   Bouchaib Bahbouhi, Nabil Georges Seidah, Elmostafa Bahraoui · 2001 · Biochemical Journal
2. Purification of the proprotein convertase furin by affinity chromatography based on PC-specific inhibitors
   Miriam Kuester, Gero L. Becker, Kornelia Hardes, Iris Lindberg, Torsten Steinmetzer, Manuel E. Than · 2011 · Biological Chemistry
3. Membrane bound modified form of clade B Env, JRCSF is suitable for immunogen design as it is efficiently cleaved and displays all the broadly neutralizing epitopes including V2 and C2 domain-dependent conformational epitopes
   Supratik Das, Saikat Boliar, N. K. Mitra, Sweety Samal, Manish Bansal, Wayne Chester Koff, Bimal K. Chakrabarti · 2016 · Retrovirology
4. βTrCP is Required for HIV-1 Vpu Modulation of CD4, GaLV Env, and BST-2/Tetherin
   Yul Eum Song, Daniel Cyburt, Tiffany M. Lucas, Devon A. Gregory, Terri D. Lyddon, Marc C. Johnson · 2018 · Viruses
5. Variable infectivity and conserved engagement in cell-to-cell viral transfer by HIV-1 Env from Clade B transmitted founder clones
   Hongru Li, Benjamin K. Chen · 2018 · Virology
6. Severe Acute Respiratory Syndrome coronavirus-2 (SARS-CoV-2) Infection: Let the Virus Be Its Own Demise
   John J. Nemunaitis, Laura Stanbery, Neil N. Senzer · 2020 · Future Virology
7. Human Ubc9 Is Involved in Intracellular HIV-1 Env Stability after Trafficking out of the Trans-Golgi Network in a Gag Dependent Manner
   Christopher R. Bohl, L. Abrahamyan, C. Wood · 2013 · PLoS ONE
8. Identification and characterization of a naturally occurring, efficiently cleaved, membrane-bound, clade A HIV-1 Env, suitable for immunogen design, with properties comparable to membrane-bound BG505
   Supratik Das, Saikat Boliar, Sweety Samal, Shubbir Ahmed, Tripti Shrivastava, Brihaspati Narayan Shukla, Sandeep Goswami, Manish Bansal, Bimal K. Chakrabarti · 2017 · Virology
9. Attachment of an oligopeptide epitope to the C-terminus of recombinant SIV gp160 facilitates the construction of SMAA complexes while preserving CD4 binding
   Thomas Hanke, Dan F. Young, Carl B. Doyle, Ian Martin Jones, Richard E. Randall · 1995 · Journal of Virological Methods
10. An Anti-HIV Peptide Construct Derived from the Cleavage Region of the Env Precursor Acts on Env Fusogenicity through the Presence of a Functional Cleavage Sequence
    Rym Barbouche, Jean‐Marc Sabatier, Emmanuel Fenouillet · 1998 · Virology
11. HIV-1 interaction with an O-glycan-specific bacterial lectin enhances virus infectivity and resistance to neutralizing antibodies
    Daniel W. Heindel, Dania M. Figueroa, Marisa Goff, Clauvis Kunkeng Yengo, Muzafar Jan, Xiaomei Liu, Xiaohong Wang, Mariya Petrova, Mo Zhang, Manish Sagar et al. · 2024 · iScience
12. miR-24-3p Is Antiviral Against SARS-CoV-2 by Downregulating Critical Host Entry Factors
    Parrish Evers, Spencer M. Uguccioni, Nadine Ahmed, Magen Ellen Francis, Alyson A. Kelvin, John Paul Pezacki · 2024 · Viruses
13. Live Cell Imaging of Retroviral Entry
    Amy E. Hulme, Thomas J. Hope · 2014 · Annual Review of Virology
14. Defining the fitness of HIV-1 isolates with dual/mixed co-receptor usage
    Immaculate Nankya, Denis M. Tebit, Awet Abraha, Fred Kyeyune, Richard M. Gibson, Oyebisi Jegede, Gabrielle C. Nickel, Eric J. Arts · 2015 · AIDS Research and Therapy
15. Stepwise Deletion of the HIV Type 1 Glycoprotein 41 N Terminus Leads to an Increasing Export of Microvesicles Containing Uncleaved Env Glycoprotein
    Ortwin Adams, Andreas Scheid · 2001 · AIDS Research and Human Retroviruses
16. Effects of l- and d-REKR amino acid-containing peptides on HIV and SIV envelope glycoprotein precursor maturation and HIV and SIV replication
    Bouchaib Bahbouhi, Nathalie Chazal, Nabil Georges Seidah, Cristina Chiva, Marcelo Javier Kogan, Fernando Alberício, Ernest Giralt, Elmostafa Bahraoui · 2002 · Biochemical Journal
17. Current drug discovery strategies against arenavirus infections
    Antonella Pasquato, Dominique Julien Burri, Stefan Kunz · 2012 · Expert Review of Anti-infective Therapy
18. Cooperative Cleavage of the R Peptide in the Env Trimer of Moloney Murine Leukemia Virus Facilitates Its Maturation for Fusion Competence
    Robin Löving, Malin Kronqvist, Mathilda Sjöberg, Henrik Garoff · 2011 · Journal of Virology
19. Processing of the envelope glycoprotein gp160 in immunotoxin-resistant cell lines chronically infected with human immunodeficiency virus type 1
    Thomas D. Duensing, H Fang, David W. Dorward, Seth H. Pincus · 1995 · Journal of Virology
20. A non-canonical binding interface in the crystal structure of HIV-1 gp120 core in complex with CD4
    Liangwei Duan, Hui Zhang, Mengting Zhao, Jixue Sun, Wen-Li Chen, Jianping Lin, Xinqi Liu · 2017 · Scientific Reports
21. Coronavirus in Hematologic Malignancies: Targeting Molecules Beyond the Angiotensin-Converting Enzyme 2 (ACE2) Wall in COVID-19
    Evangelos Tsiambas, VASILEIOS S. PAPANIKOLAOU, Aristeidis Chrysovergis, NICHOLAS S. MASTRONIKOLIS, Vasileios Ragos, Nikolaos Kavantzas, Andreas Ch Lazaris, Efthymios Kyrodimos · 2020 · Pathology & Oncology Research
22. The gag proteins of human immunodeficiency virus type 1: mechanisms of virus assembly and possibilities for interference
    Susanne Modrow, Bernhard Kattenbeck, Andreas von Poblotzki, Matthias Niedrig, Ralf Wagner, Hans J. Wolf · 1994 · Medical Microbiology and Immunology
23. Rational Problems Associated with the Development of Cellular Approaches in Controlling HIV Spread
    Aldar S. Bourinbaiar, Sylvia Lee‐Huang · 1995 · Advances in experimental medicine and biology
24. Kex2p: a model for cellular endoprotease processing human immunodeficiency virus type 1 envelope glycoprotein precursor
    Maxime Moulard, Tilman Achstetter, Marie-Paule Kiény, Luc Montagnier, Elmostafa Bahraoui · 1994 · European Journal of Biochemistry
25. Host proteases: key regulators in viral infection and therapeutic targeting
    Qiongrong Xia, Xiaohua Liu, Huacui Huang · 2025 · Frontiers in Immunology
26. Inhibitors of signal peptide peptidase and subtilisin/kexin-isozyme 1 inhibit Ebola virus glycoprotein-driven cell entry by interfering with activity and cellular localization of endosomal cathepsins
    Teresa Plegge, Martin Spiegel, Nadine Krüger, Inga Nehlmeier, Michael Winkler, Mariana González-Hernández, Stefan Pöhlmann · 2019 · PLoS ONE
27. SARS-CoV-2 S Mutations: A Lesson from the Viral World to Understand How Human Furin Works
    Leonardo Cassari, Angela Pavan, Giulia Zoia, Monica Chinellato, Elena Zeni, Alessandro Grinzato, Sylvia Rothenberger, Laura Cendron, Monica Dettin, Antonella Pasquato · 2023 · International Journal of Molecular Sciences
28. Molecular Recognition of HIV Glycans by Antibodies
    Leopold Kong, Robyn L. Stanfield, Ian A. Wilson · 2013 · Springer eBooks
29. Glycoproteins of HHV-6A and HHV-6B
    Huamin Tang, Yasuko Mori · 2018 · Advances in experimental medicine and biology
30. Recent Progress in the Development of HIV-1 Entry Inhibitors: From Small Molecules to Potent Anti-HIV Agents
    Khomson Suttisintong, Narongpol Kaewchangwat, Eknarin Thanayupong, Chakkrapan Nerungsi, Onsiri Srikun, Pornpan Pungpo · 2019 · Current Topics in Medicinal Chemistry
31. Antigenic properties of a transport-competent influenza HA/HIV Env chimeric protein
    尚道 鳥宮, Yuliang Sun, Jianguo Lin, Zhigao Bu, Qingyang Wu, Shibo Jiang, David A. Steinhauer, Richard W. Compans, Chinglai Yang · 2006 · Virology
32. Activity of the Mason-Pfizer Monkey Virus Fusion Protein Is Modulated by Single Amino Acids in the Cytoplasmic Tail
    Chisu Song, Keith Micoli, Eric Hunter · 2005 · Journal of Virology
33. Human Immunodeficiency Virus Type 1-Associated Cd4 Downmodulation
    Romas Geleziunas, Stephan P. Bour, Mark A. Wainberg · 1994 · Advances in virus research
34. Roles of Reactive Oxygen Species in Relationships Between Viral Infections and Alzheimer’s Disease and Related Dementia
    Gunel Ayyubova, Fariha E Bablu, Nazrin Rahimli, Leyla Aghayeva, Elijah M. Springer, Fada Alghenaim, Yuichiro J. Suzuki · 2026 · Antioxidants
35. Structural insights into Furin enzyme inhibition to block SARS-CoV-2 spike protein cleavage: an in-silico approach
    Jaganathan Ramakrishnan, P. Kumaradhas · 2024 · 3 Biotech
36. gp120 Envelope Glycoproteins of HIV-1 Group M Subtype A and Subtype B Differentially Affect Gene Expression in Human Vascular Endothelial Cells
    Andrew J. Suh, Dante I. Suzuki, Sergiy G. Gychka, Tinatin I. Brelidze, Yuichiro Suzuki · 2023 · International Journal of Molecular Sciences
37. Study of the HIV-2 Env Cytoplasmic Tail Variability and Its Impact on Tat, Rev and Nef
    Nordine Bakouche, Anne-Thérèse Vandenbroucke, Patrick Goubau, Jean Ruelle · 2013 · PLoS ONE
38. Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS)
    Narenda Kumar, Rajiv Kumar · 2014 · Elsevier eBooks
39. Exclusive Decoration of Simian Immunodeficiency Virus Env with High-Mannose Type N-Glycans Is Not Compatible with Mucosal Transmission in Rhesus Macaques
    Christina B. Karsten, Falk F. R. Buettner, Samanta Cajic, Inga Nehlmeier, Berit Neumann, Antonina Klippert, Ulrike Sauermann, Udo Reichl, Rita Gerardy‐Schahn, Erdmann Rapp et al. · 2015 · Journal of Virology
40. The Envelope Cytoplasmic Tail of HIV-1 Subtype C Contributes to Poor Replication Capacity through Low Viral Infectivity and Cell-to-Cell Transmission
    Eveline Santos da Silva, Martin M. Mulinge, Morgane Lemaire, Cécile Masquelier, Cyprien Beraud, Arkadiusz Rybicki, Jean-Yves Servais, Gilles Iserentant, Jean‐Claude Schmit, Carole Seguin‐Devaux et al. · 2016 · PLoS ONE
41. Efficiently cleaved HIV-1 envelopes: can they be important for vaccine immunogen development?
    Supratik Das, Rajesh Kumar, Shubbir Ahmed, Hilal Ahmad Parray, Sweety Samal · 2020 · Therapeutic Advances in Vaccines and Immunotherapy
42. Employing Broadly Neutralizing Antibodies as a Human Immunodeficiency Virus Prophylactic & Therapeutic Application
    Chengchao Ding, Darshit Patel, Yunjing Ma, Jamie F. S. Mann, Jianjun Wu, Yong Gao · 2021 · Frontiers in Immunology
43. Review
    1996 · Biological Chemistry Hoppe-Seyler
44. The hyperglycosylation of HIV envelope: An opportunity to alter virus infectivity?
    Emmanuel Fenouillet, Ian Martin Jones · 1996 · Perspectives in Drug Discovery and Design
45. PEGylation of a proprotein convertase peptide inhibitor for vaginal route of drug delivery: In vitro bioactivity, stability and in vivo pharmacokinetics
    Hui-Ting Ho, Tracy L. Nero, Harmeet Singh, Michael W. Parker, Guiying Nie · 2012 · Peptides
46. Second site reversion of HIV-1 envelope protein baseplate mutations maps to the matrix protein
    Ayna Alfadhli, CeAnn Romanaggi, Robin Lid Barklis, Eric Barklis · 2024 · Journal of Virology
47. Glycoprotein B of equine herpesvirus type 1 has two recognition sites for subtilisin-like proteases that are cleaved by furin
    Bart Spiesschaert, Heike Stephanowitz, Eberhard Krause, Nikolaus Osterrieder, Walid Azab · 2016 · Journal of General Virology
48. A novel cell‐based sensor detecting the activity of individual basic proprotein convertases
    Karin Löw, Kornelia Hardes, Chiara Fedeli, Nabil Georges Seidah, Daniel B. Constam, Antonella Pasquato, Torsten Steinmetzer, Alexandre Roulin, Stefan Kunz · 2019 · FEBS Journal
49. Assessment of HIV vaccine development: Past, present, and future
    Michael W. Cho · 2000 · Advances in pharmacology
50. Structural Investigation of the HIV‐1 Envelope Glycoprotein gp160 Cleavage Site 3: Role of Site‐Specific Mutations
    Lucia Falcigno, Romina Oliva, Gabriella D’Auria, Massimiliano Maletta, Monica Dettin, Antonella Pasquato, Carlo Di Bello, Livio Paolillo · 2004 · ChemBioChem
51. Systematic Analysis of Intracellular Trafficking Motifs Located within the Cytoplasmic Domain of Simian Immunodeficiency Virus Glycoprotein gp41
    Thomas S. Postler, Jacqueline G. Bixby, Ronald C. Desrosiers, Eloísa Yuste · 2014 · PLoS ONE
52. Novel strategy for the selection of human recombinant Fab fragments to membrane proteins from a phage-display library
    Aran F. Labrijn, Marco Koppelman, Janneke Verhagen, Mieke C. Brouwer, Hanneke Schuitemaker, C. Erik Hack, Han G. Huisman · 2002 · Journal of Immunological Methods
53. Enhanced Proteolytic Processing of the Human Immunodeficiency Virus Type 1 Envelope Protein in Murine Ltk(-) Cells
    Dolores Rodrı́guez, Juan Ramón Rodríguez, Mariano Estéban · 1995 · AIDS Research and Human Retroviruses
54. Bioinformatic Prediction of Interaction between Flavonoids of Propolis of Honey Bee and Envelope Glycoprotein GP120
    Shahin Gavanji, Behrouz Larki, Forogh Mortazaeinezhad · 2014 · International Journal of Scientific Research in Environmental Sciences
55. [4] Use of vaccinia virus vectors to study neuropeptide processing
    Judy K. VanSlyke, Laurel Thomas, Gary Thomas · 1995 · Methods in neurosciences
56. Short Communication: Pharmacophore Determination of a gp120 C Terminal-Derived Anti-HIV Peptide Construct Interfering with Membrane Fusion Suggesting That Processing of the gp120 C Terminus Is a Prelude to Fusion
    Mohamed‐Ridha Barbouche, Eric Feyfant, B. Belhaj, Emmanuel Fenouillet · 2002 · AIDS Research and Human Retroviruses
57. Design of Polypeptides
    Bernd Gutte, Stephan Klauser · 1995 · Elsevier eBooks
58. Beyond reverse transcription: molecular mechanisms and emerging paradigms in retroviral replication
    Jehad, Mohammad Abdullah, Ali, Lizna M, Pillai, Vineeta N, Prabhu, Suresha G, Mustafa, Farah, Rizvi, Tahir A · 2026 · FEMS Microbiology Reviews
59. Tryptophan-based motifs in the LLP3 region of the HIV-1 envelope glycoprotein cytoplasmic tail direct trafficking to the endosomal recycling compartment and mediate particle incorporation
    Grigoriy Lerner, Lingmei Ding, Paul W. Spearman · 2023 · Journal of Virology
60. The Role of Proprotein Convertases in Upper Airway Remodeling
    Sang‐Nam Lee, Joo‐Heon Yoon · 2022 · Molecules and Cells
61. N-Linked Glycosylation-Dependent and -Independent Mechanisms Regulating CTRP12 Cleavage, Secretion, and Stability
    Ashley N. Stewart, Stefanie Y. Tan, David J. Clark, Hui Zhang, Guang William Wong · 2018 · Biochemistry
62. Organization of HIV-1 pol Is Critical for Pol Polyprotein Processing
    Yu-Chung Chang, Sung‐Liang Yu, Wan‐Jr Syu · 1999 · Journal of Biomedical Science
63. Host protein atlastin-1 promotes human immunodeficiency virus (HIV-1) replication
    Wenyuan Shen, Bin Liu, Zhou Liu, Jiabin Feng, Chang Liu, Xiaohong Kong · 2017 · Virologica Sinica
64. Ligand accessibility to the HIV-1 Env co-receptor binding site can occur prior to CD4 engagement and is independent of viral tier category
    Saikat Boliar, Shilpa A. Patil, Brihaspati Narayan Shukla, Ali Ghobbeh, Suprit Deshpande, Weizao Chen, Javier Guenaga, Dimiter Stanchev Dimitrov, Richard T. Wyatt, Bimal K. Chakrabarti · 2018 · Virology
65. HIV infection and oligosaccharides: A novel approach to preventing HIV infection and the onset of AIDS
    Tsuguo Mizuochi, Munehiro Nakata · 1999 · Journal of Infection and Chemotherapy
66. Structural Investigation of the HIV‐1 Envelope Glycoprotein gp160 Cleavage Site, 2: Relevance of an N‐Terminal Helix
    Romina Oliva, Lucia Falcigno, Gabriella D’Auria, Monica Dettin, Claudia Scarinci, Antonella Pasquato, Carlo Di Bello, Livio Paolillo · 2003 · ChemBioChem
67. Natural Variation in the Amino Acid Sequence around the HIV Type 1 Glycoprotein 160 Cleavage Site and Its Effect on Cleavability, Subunit Association, and Membrane Fusion
    Ortwin Adams, Heiner Schaal, Andreas Scheid · 2000 · AIDS Research and Human Retroviruses
68. T4-lymphocyte endoprotease responsible for the proteolytic processing of HIV-1 GP160, like Kex2p endoprotease, is a calcium-dependent enzyme
    Maxime Moulard, Tilman Achstetter, Yuzuru Ikehara, Elmostafa Bahraoui · 1994 · Biochimie
69. Properties of HIV envelope expressed in the presence of SPC3, an Env‐derived peptide drug under phase II clinical trials
    Mohamed‐Ridha Barbouche, Emmanuel Fenouillet, Marie‐Jeanne Papandréou, Marie Paule Kiény, Jean‐Marc Sabatier · 1998 · Journal of Peptide Research
70. Beyond Processing: Furin as a Central Hub in Viral Pathogenesis and Genetic Susceptibility
    Adrián Alejandro Silva-Ríos, Carlos Ernesto Mora-Ornelas, Luna Galilea Flores-Medina, José Francisco Muñóz-Valle, Carlos Daniel Díaz-Palomera, Mariel García‐Chagollán, Alexis Missael Vizcaíno‐Quirarte, Oliver Viera Segura · 2025 · Biomolecules
71. Structural characteristics of Heparan sulfate required for the binding with the virus processing Enzyme Furin
    Jiaxin Zeng, Yuan Meng, Shiyi Chen, Gaofeng Zhao, Lianchun Wang, Enxin Zhang, Hong Ying Qiu · 2021 · Glycoconjugate Journal
72. Furin Regulates the Alveolarization of Neonatal Lungs in a Mouse Model of Hyperoxic Lung Injury
    Shin Kato, Osuke Iwata, Hiroyuki Kato, Satoko Fukaya, Yukari Imai, Shinji Saitoh · 2023 · Biomolecules
73. Membrane-Active Sequences within gp41 Membrane Proximal External Region (MPER) Modulate MPER-Containing Peptidyl Fusion Inhibitor Activity and the Biosynthesis of HIV-1 Structural Proteins
    Si Min Zhang, Alenka Jejcic, James P. Tam, Anders G. Vahlne · 2015 · PLoS ONE
74. The role of the envelope glycoproteins in HIV-1 transmission and pathogenesis
    Quentin James Sattentau · 1996 · Perspectives in Drug Discovery and Design
75. Functional Chimeras of Human Immunodeficiency Virus Type 1 gp120 and Influenza A Virus (H3) Hemagglutinin
    Kiel Copeland, Alex James Elliot, R. S. Daniels · 2005 · Journal of Virology
76. High dose cocaine use in Bolivia and Peru.
    Michael Gossop, M Butron, M Molla · 1994 · PubMed
77. Furin
    Sean S. Molloy, Gary Thomas · 2002 · The Enzymes
78. Entrada del virus de la inmunodeficiencia humana en las células: mecanismos y posibilidades terapéuticas
    Verónica Briz, Eva Poveda, Vincent Soriano · 2006 · Medicina Clínica
79. Does Virus-Receptor Interplay Influence Human Coronaviruses Infection Outcome?
    Jolanta Bratosiewicz‐Wąsik, Tomasz J. Wąsik · 2020 · Medical Science Monitor
80. Functional analysis of a novel baculovirus envelope fusion protein
    Marcel Westenberg · 2004
81. SPC3, an anti-HIV peptide construct derived from the viral envelope, binds and enters HIV target cells
    Rym Barbouche, Raymond Miquelis, Jean‐Marc Sabatier, Emmanuel Fenouillet · 1999 · Journal of Peptide Science
82. Inhibition of HIV-2ROD replication in a lymphoblastoid cell line by the α1-antitrypsin Portland variant (α1-PDX) and the decRVKRcmk peptide: comparison with HIV-1LAI
    Bouchaib Bahbouhi, Mourad Bendjennat, Cristina Chiva, Marcelo Javier Kogan, Fernando Alberício, Ernest Giralt, Nabil Georges Seidah, Elmostafa Bahraoui · 2001 · Microbes and Infection
83. Implications of Spike-glycoprotein processing at S1/S2 by Furin, at S2’ by Furin and/or TMPRSS2 and shedding of ACE2: cell-to-cell fusion, cell entry and infectivity of SARS-CoV-2
    Rachid Essalmani, Jaspreet Jain, Delia Susan‐Resiga, Ursula Andréo, Alexandra Evagelidis, Rabeb Mouna Derbali, David N. Huynh, Frédéric Dallaire, Mélanie Laporte, Adrien Delpal et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory) · Retracted
84. Molecular basis of viral pathogenicity
    1995 · Uirusu
85. Macrophage- and CD4+ T cell-derived SIV differ in glycosylation, infectivity and neutralization sensitivity
    Christina B. Karsten, Falk F. R. Buettner, Samanta Cajic, Inga Nehlmeier, Berit Roshani, Antonina Klippert, Ulrike Sauermann, Nicole Stolte, Udo Reichl, Rita Gerardy‐Schahn et al. · 2024 · PLoS Pathogens
86. HIV-1 Glycoprotein Immunogenicity
    Fahd Benjelloun, Christian Genin, Stéphane Paul · 2011 · InTech eBooks
87. Inhibition of proprotein convertase 5/6 activity: potential for nonhormonal women-centered contraception
    Mohamad Aljofan, Harmeet Singh, Hui-Ting Ho, Shuwu Xie, Yan Zhu, Zhaogui Sun, Xiangjie Guo, Jian Wang, Guiying Nie · 2011 · Contraception
88. Comparison Between Flow Cytometry and Bead Method in Counting Cd4 and Cd8 T Lymphocytes in Mouse Spleen Cells Suspension
    Abdulrahman Abdalla Allabidi · 2014 · CORE Scholar (Wright State University)
89. Large Multidomain Protein NMR: HIV-1 Reverse Transcriptase Precursor in Solution
    Tatiana V. Ilina, Zhaoyong Xi, Teresa A. Brosenitsch, Nicolas Sluis‐Cremer, Rieko Ishima · 2020 · International Journal of Molecular Sciences
90. Human Immunodeficiency Virus From Virus Structure to Pathogenesis
    Hans R. Gelderblom, Klaus Böller · 2005 · Kluwer Academic Publishers eBooks
91. Therapeutic Potential of Furin Inhibition: An Evaluation Using a Conditional Furin Knockout Mouse Model
    Jeroen Declercq, John W.M. Creemers · 2012 · Colloquium Series on Protein Activation and Cancer
92. Furin
    Jeroen Declercq, John W.M. Creemers · 2012 · Handbook of Proteolytic Enzymes
93. Penetration of baculoviruses into cell: Universal mechanism and intriguing details
    I. M. Kikhno · 2009 · Molecular Genetics Microbiology and Virology
94. Vaccinia Virus Recombinants: Expression Vectors and Potential Vaccines
    Mike Mackett · 1994 · Elsevier eBooks
95. Aspects of Viral Morphogenesis and of Processing and Transport of Viral Glycoproteins
    K. Radsak, H. Kern, Bernardo Sgarbi Reis, M. Reschke, Th. Mockenhaupt, Markus Eickmann · 1995
96. Recruitment of Env to the HIV-1 T cell virological synapse by targeted and sustained Env recycling
    Lili Wang, Alice Sandmeyer, Wolfgang Hübner, Hongru Li, Thomas R. Huser, Benjamin K. Chen · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
97. Incorporation of the HIV-1 envelope glycoprotein into viral particles is regulated by the tubular recycling endosome in a cell type-specific manner
    Grigoriy Lerner, Lingmei Ding, Kathleen Candor, Paul W. Spearman · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
98. Therapeutic Approaches to HIV Infection Based on Virus Structure and the Host Pathogen Interaction
    C. David Pauza, Daniel N. Streblow · 1995 · Current topics in microbiology and immunology
99. Inhibition of furin-like enzymatic activities and SARS-CoV-2 infection by osthole and phenolic compounds with aryl side chains
    Yuka Kiba, Takashi Tanikawa, Tsuyoshi Hayashi, Hitoshi Kamauchi, Taishi Seki, Ryuichiro Suzuki, Masashi Kitamura · 2023 · Biomedicine & Pharmacotherapy
100. Endocytic motif on HIV-1 Env regulates cleavage status and antibody neutralization of cell-free and cell-to-cell infection
     Dania M. Figueroa, Tony R. Valencia, Hongru Li, Benjamin K. Chen · 2026 · Journal of Virology